A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Condition: Type 2 Diabetes MellitusInterventions: Drug: MK-3102; Drug: Placebo to MK-3102; Drug: Glipizide; Drug: Placebo to glipizide; Biological: InsulinSponsor: Merck Sharp & Dohme Corp.Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2012 Category: Research Source Type: clinical trials
A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Condition: Type 2 Diabetes MellitusInterventions: Drug: MK-3102; Drug: Placebo to MK-3102; Drug: Glipizide; Drug: Placebo to glipizide; Biological: InsulinSponsor: Merck Sharp & Dohme Corp.Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2012 Category: Research Source Type: clinical trials
A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Condition: Type 2 Diabetes MellitusInterventions: Drug: MK-3102; Drug: Placebo to MK-3102; Drug: Glipizide; Drug: Placebo to glipizide; Biological: InsulinSponsor: Merck Sharp & Dohme Corp.Active, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2012 Category: Research Source Type: clinical trials
Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients
Condition: Type 2 DiabetesInterventions: Drug: dapagliflozin; Drug: glipizide; Drug: metformin hydrochlorideSponsors: AstraZeneca; Bristol-Myers SquibbCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2008 Category: Research Source Type: clinical trials
MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
Condition: Diabetes Mellitus, Type 2Intervention: Drug: MK0767Sponsor: Merck Sharp & Dohme Corp.Terminated - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2007 Category: Research Source Type: clinical trials